These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacology. Stump CA; Cooke AJ; Bruno J; Cabalu TD; Gotter AL; Harell CM; Kuduk SD; McDonald TP; O'Brien J; Renger JJ; Williams PD; Winrow CJ; Coleman PJ Bioorg Med Chem Lett; 2016 Dec; 26(23):5809-5814. PubMed ID: 27818110 [TBL] [Abstract][Full Text] [Related]
6. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand? Hoyer D; Jacobson LH Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799 [TBL] [Abstract][Full Text] [Related]
7. Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements. Roecker AJ; Mercer SP; Bergman JM; Gilbert KF; Kuduk SD; Harrell CM; Garson SL; Fox SV; Gotter AL; Tannenbaum PL; Prueksaritanont T; Cabalu TD; Cui D; Lemaire W; Winrow CJ; Renger JJ; Coleman PJ Bioorg Med Chem Lett; 2015 Nov; 25(21):4992-4999. PubMed ID: 25613676 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists. Yoshida Y; Terauchi T; Naoe Y; Kazuta Y; Ozaki F; Beuckmann CT; Nakagawa M; Suzuki M; Kushida I; Takenaka O; Ueno T; Yonaga M Bioorg Med Chem; 2014 Nov; 22(21):6071-88. PubMed ID: 25267004 [TBL] [Abstract][Full Text] [Related]
9. Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders. Di Fabio R; Pellacani A; Faedo S; Roth A; Piccoli L; Gerrard P; Porter RA; Johnson CN; Thewlis K; Donati D; Stasi L; Spada S; Stemp G; Nash D; Branch C; Kindon L; Massagrande M; Poffe A; Braggio S; Chiarparin E; Marchioro C; Ratti E; Corsi M Bioorg Med Chem Lett; 2011 Sep; 21(18):5562-7. PubMed ID: 21831639 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors. Atwal KS; O'Neil SV; Ahmad S; Doweyko L; Kirby M; Dorso CR; Chandrasena G; Chen BC; Zhao R; Zahler R Bioorg Med Chem Lett; 2006 Sep; 16(18):4796-9. PubMed ID: 16870436 [TBL] [Abstract][Full Text] [Related]
11. Identification of a novel series of orexin receptor antagonists with a distinct effect on sleep architecture for the treatment of insomnia. Betschart C; Hintermann S; Behnke D; Cotesta S; Fendt M; Gee CE; Jacobson LH; Laue G; Ofner S; Chaudhari V; Badiger S; Pandit C; Wagner J; Hoyer D J Med Chem; 2013 Oct; 56(19):7590-607. PubMed ID: 23964859 [TBL] [Abstract][Full Text] [Related]
12. Identification of highly selective and potent orexin receptor 1 antagonists derived from a dual orexin receptor 1/2 antagonist based on the structural framework of pyrazoylethylbenzamide. Futamura A; Nozawa D; Araki Y; Tamura Y; Tokura S; Kawamoto H; Tokumaru Y; Kakihara S; Aoki T; Ohtake N Bioorg Med Chem; 2017 Oct; 25(20):5203-5215. PubMed ID: 28807572 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship studies and sleep-promoting activity of novel 1-chloro-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine derivatives as dual orexin receptor antagonists. Part 2. Sifferlen T; Koberstein R; Cottreel E; Boller A; Weller T; Gatfield J; Brisbare-Roch C; Jenck F; Boss C Bioorg Med Chem Lett; 2013 Jul; 23(13):3857-63. PubMed ID: 23719231 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain. Lan Y; Chen Y; Cao X; Zhang J; Wang J; Xu X; Qiu Y; Zhang T; Liu X; Liu BF; Zhang G J Med Chem; 2014 Dec; 57(24):10404-23. PubMed ID: 25420090 [TBL] [Abstract][Full Text] [Related]